Virtu Financial’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-143,537
| Closed | -$27K | – | 2060 |
|
|
2024
Q1 | $27K | Buy |
143,537
+131,248
| +1,068% | +$64K | ﹤0.01% | 1129 |
|
|
2023
Q4 | $14K | Buy |
+12,289
| New | +$17.6K | ﹤0.01% | 1377 |
|
|
2023
Q3 | – | Sell |
-471
| Closed | -$3K | – | 2084 |
|
|
2023
Q2 | $3K | Sell |
471
-126
| -21% | -$2.11K | ﹤0.01% | 1423 |
|
|
2023
Q1 | $17K | Buy |
597
+358
| +150% | +$17.4K | ﹤0.01% | 1283 |
|
|
2022
Q4 | $16K | Buy |
+239
| New | +$34.4K | ﹤0.01% | 1312 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | -$5K | – | 2201 |
|
|
2021
Q4 | $5K | Sell |
5
-79
| -94% | -$99.6K | ﹤0.01% | 1614 |
|
|
2021
Q3 | $133K | Sell |
84
-4
| -5% | -$6.53K | 0.01% | 1046 |
|
|
2021
Q2 | $154K | Buy |
+88
| New | +$163K | 0.02% | 1083 |
|
|
2021
Q1 | – | Sell |
-57
| Closed | -$60K | – | 2142 |
|
|
2020
Q4 | $60K | Sell |
57
-51
| -47% | -$38.9K | 0.01% | 1189 |
|
|
2020
Q3 | $74K | Buy |
108
+103
| +2,060% | +$96.6K | 0.01% | 763 |
|
|
2020
Q2 | $6K | Buy |
+5
| New | +$5.69K | ﹤0.01% | 1192 |
|
|
2019
Q4 | $16K | Buy |
+12
| New | +$18.5K | ﹤0.01% | 1343 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | -$27K | – | 2072 |
|
|
2018
Q3 | $27K | Buy |
+5
| New | +$20K | ﹤0.01% | 1379 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$7K | – | 2754 |
|
|
2017
Q4 | $7K | Sell |
1
-3
| -75% | -$21.1K | ﹤0.01% | 2277 |
|
|
2017
Q3 | $33K | Buy |
+4
| New | +$34.5K | ﹤0.01% | 2281 |
|
Other funds holding BIOL
Virtu Financial's BIOL Position: Q2 2024 in Review
Virtu Financial sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 143,537 shares — an estimated $27K sold.
Virtu Financial first reported a position in BIOL in Q3 2017 and held it in 15 quarters. The position peaked at $154K in Q2 2021. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.
- Virtu Financial reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
- Virtu Financial sold 143,537 Biolase, Inc. shares in Q2 2024, an estimated $27K.
- Virtu Financial first reported a position in Biolase, Inc. in Q3 2017 and held it in 15 quarters.
- Virtu Financial's Biolase, Inc. position peaked at $154K in Q2 2021.
- 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.
Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.